GENEVA, Jan. 7 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2025/035797) for "6-MEMBERED CORE COMPOUNDS AS MODULATORS OF WERNER SYNDROME RECQ DNA HELICASE AND USES THEREOF" on Jun 27, 2025. With publication no. WO/2026/006805, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TAMAYO, Nuria A. (One Amgen Center DriveLaw Department-Patent Operations MS 28-5-AThousand Oaks, California 91320-1799), ALAFATE, Adili (One Amgen Center DriveLaw Department-Patent Operati...